Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Tue, 19.08.2025
PNE AG
Company Name:
PNE AG
ISIN:
DE000A0JBPG2
Reason for the research:
Update
Recommendation:
Buy
from:
19.08.2025
Target price:
19,00 Euro
Target price on sight of:
12 Monate
Last rating change:
02.02.2023: Hochstufung von Hinzufügen auf Kaufen
Analyst:
Dr. Karsten von Blumenthal
First Berlin Equity Research hat ein Research U [ … ]
Tue, 19.08.2025
Valneva SE
Company Name:
Valneva SE
ISIN:
FR0004056851
Reason for the research:
Q2 results
Recommendation:
Buy
from:
19.08.2025
Target price:
€8.10
Target price on sight of:
12 months
Last rating change:
-
Analyst:
Simon Scholes
First Berlin Equity Research has published a research update on Valneva SE (ISIN: FR0004056851). Analyst [ … ]
Mon, 18.08.2025
Energiekontor AG
Company Name:
Energiekontor AG
ISIN:
DE0005313506
Reason for the research:
Update
Recommendation:
Buy
from:
18.08.2025
Target price:
105,00 Euro
Target price on sight of:
12 Monate
Last rating change:
18.10.2022: Hochstufung von Hinzufügen auf Kaufen
Analyst:
Dr. Karsten von Blumenthal
First Berlin Equity Research hat ein [ … ]
Mon, 18.08.2025
Lisata Therapeutics Inc
Company Name:
Lisata Therapeutics Inc
ISIN:
US1280583022
Reason for the research:
Update
Recommendation:
BUY
from:
18.08.2025
Target price:
USD 15.00
Target price on sight of:
12 months
Last rating change:
-
Analyst:
Christian Orquera
First Berlin Equity Research has published a research update on Lisata Therapeutics, Inc. (IS [ … ]
Mon, 18.08.2025
Verve Group SE
Company Name:
Verve Group SE
ISIN:
SE0018538068
Reason for the research:
Sechsmonatsbericht
Recommendation:
Kaufen
from:
18.08.2025
Target price:
€4,80
Target price on sight of:
12 Monate
Last rating change:
-
Analyst:
Ellis Acklin
First Berlin Equity Research hat ein Research Update zu Verve Group SE (ISIN: SE0018538068) [ … ]
Thu, 14.08.2025
Deutsche Effecten- und Wechsel- Beteiligungsgesellschaft AG
Company Name:
Deutsche Effecten- und Wechsel- Beteiligungsgesellschaft AG
ISIN:
DE0008041005
Reason for the research:
Update
Recommendation:
BUY
from:
14.08.2025
Target price:
€1.50
Target price on sight of:
12 months
Last rating change:
-
Analyst:
Christian Orquera
irst Berlin Equity Research has published a research upd [ … ]
Thu, 14.08.2025
Grand City Properties SA
Company Name:
Grand City Properties SA
ISIN:
LU0775917882
Reason for the research:
Sechsmonatsbericht
Recommendation:
Kaufen
from:
14.08.2025
Target price:
€15
Target price on sight of:
12 Monate
Last rating change:
-
Analyst:
Ellis Acklin
First Berlin Equity Research hat ein Research Update zu Grand City Properties S.A. [ … ]
Tue, 12.08.2025
Knaus Tabbert AG
Company Name:
Knaus Tabbert AG
ISIN:
DE000A2YN504
Reason for the research:
Sechsmonatsbericht
Recommendation:
Kaufen
from:
12.08.2025
Target price:
€27
Target price on sight of:
12 Monate
Last rating change:
-
Analyst:
Ellis Acklin
First Berlin Equity Research hat ein Research Update zu Knaus Tabbert AG (ISIN: DE000A2YN50 [ … ]
Tue, 12.08.2025
Cardiol Therapeutics Inc
Company Name:
Cardiol Therapeutics Inc
ISIN:
CA14161Y2006
Reason for the research:
Update
Recommendation:
BUY
from:
12.08.2025
Target price:
USD 8.50
Target price on sight of:
12 months
Last rating change:
-
Analyst:
Christian Orquera
First Berlin Equity Research has published a research update on Cardiol Therapeutics Inc. (IS [ … ]
Thu, 07.08.2025
SFC Energy AG
Company Name:
SFC Energy AG
ISIN:
DE0007568578
Reason for the research:
Update
Recommendation:
Buy
from:
07.08.2025
Target price:
26,00 Euro
Target price on sight of:
12 Monate
Last rating change:
16.02.2021: Hochstufung von Hinzufügen auf Kaufen
Analyst:
Dr. Karsten von Blumenthal
First Berlin Equity Research hat ein Res [ … ]
